CSIMarket
 
Bio rad Laboratories Inc   (BIO)
Other Ticker:  
 
 
Price: $333.5100 $1.11 0.334%
Day's High: $336.364 Week Perf: -3.12 %
Day's Low: $ 328.14 30 Day Perf: 1.71 %
Volume (M): 167 52 Wk High: $ 494.05
Volume (M$): $ 55,629 52 Wk Avg: $363.81
Open: $328.14 52 Wk Low: $261.59



 Market Capitalization (Millions $) 9,741
 Shares Outstanding (Millions) 29
 Employees 7,900
 Revenues (TTM) (Millions $) 2,671
 Net Income (TTM) (Millions $) -637
 Cash Flow (TTM) (Millions $) -30
 Capital Exp. (TTM) (Millions $) 157

Bio Rad Laboratories Inc
Bio-Rad Laboratories Inc.
is a multinational developer and manufacturer of life science research products and clinical diagnostics.
The company is headquartered in Hercules, California, and has operations in more than 100 countries worldwide.
Founded in 1952 by David and Alice Schwartz, the company initially produced specialty chemicals for the scientific research community.
As its reputation grew, the company began to develop and manufacture innovative products for use in microbiology, genetics, protein research, and other life science applications.
Today, Bio-Rad is one of the world's leading manufacturers of laboratory products and diagnostic systems.
Bio-Rad's life science division serves customers in research universities, biotechnology and pharmaceutical companies, and clinical research organizations.
Its product portfolio includes reagents, instruments, and software for genomic research, proteomics, cell biology, and other applications.
The company's clinical diagnostics division develops and manufactures a wide range of products for the diagnosis and treatment of diseases.
Bio-Rad is a leading provider of blood typing and transfusion testing products, as well as systems for monitoring infectious diseases, diabetes, and autoimmunity.
Bio-Rad is committed to sustainability and corporate responsibility, and its products are designed to reduce waste and improve laboratory efficiency.
The company is also involved in numerous philanthropic initiatives, including support for science education and research.
Overall, Bio-Rad Laboratories Inc.
is a respected leader in the life science research and diagnostic industry, known for its innovative products and commitment to excellence.


   Company Address: 1000 Alfred Nobel Drive, Hercules, 94547 CA
   Company Phone Number: 724-7000   Stock Exchange / Ticker: NYSE BIO
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Bio Rad Laboratories Inc

Bio-Rad Laboratories Inc. Sees Revenue Dip of -6.621% in Q4 2023 Amidst Earnings Decline

Bio-Rad Laboratories Inc, a global leader in life science research and clinical diagnostics products, has recently released its financial results for the fourth quarter of 2023 earnings season. The numbers reveal some interesting facts about the company's performance.
Firstly, the earnings per share (EPS) for the quarter saw a significant decline of -56.74% to $12.15 per share, compared to $28.08 per share in the same period the previous year. However, in a positive turn of events, the EPS increased by 233.79% from $3.64 per share in the prior financial reporting period.

Bio Rad Laboratories Inc

Bio Rad Laboratories Inc. Sees Decline in Revenue Amidst Challenging Third Quarter of 2023



Bio Rad Laboratories Inc, a leading global provider of life science research and clinical diagnostic products, posted impressive financial results for the most recent fiscal period. Despite a decrease in revenue, the company managed to turn around its profitability by presenting a significant increase in Income per Share. This article will analyze Bio Rad Laboratories Inc's financial performance and discuss its future prospects.
Body:
1. Revenue Decline and Profitability Turnaround:
Bio Rad Laboratories Inc experienced a revenue decline of -7.215%, with revenue falling from $680.80 million to $631.68 million compared to the same period a year ago. However, the company managed to reverse its fortunes by reporting a net income of $106.257 million, a substantial improvement compared to a net loss of $-164.232 million in the previous year. This transformation in profitability is reflected in the impressive increase in Income per Share from a loss of $-5.52 to $3.64.

Bio Rad Laboratories Inc

Bio Rad Laboratories Inc. Faces Shocking 1.536% Top-Line Decrease in Q2 2023 Amidst Deteriorating Business Performance? Losses Increase to $39.59 per Share


Introduction
Bio-Rad Laboratories Inc, a leading global provider of life science research solutions, recently faced a challenging financial quarter with deteriorating business performance and growing losses. The April to June 2023 financial time-frame proved to be grim as revenue declined by 1.536% to $680.48 million, resulting in a deficit per share of $-39.59, compared to $-31.12 per share in the same quarter the previous year. This article will highlight notable facts about the company's performance during this period.
Financial Decline and Losses
In the April to June 2023 financial time-frame, Bio-Rad Laboratories Inc reported a net deficit of $-1,162.251 million, a significant increase from $-927.184 million in the same period a year ago. These mounting losses are cause for concern and indicate potential financial distress for the company.

Bio Rad Laboratories Inc

Bio Rad Laboratories Inc Surpasses Expectations in First Quarter Fiscal Results, Propelling Growth and Innovation

Bio Rad Laboratories Inc: A Look at the Company's First Quarter Fiscal Results for 2023
Bio Rad Laboratories Inc is a biotechnology and pharmaceuticals company that operates in the United States and internationally. The company strives to deliver innovative products and solutions for life science research and clinical diagnostics to enable scientists and healthcare professionals to produce better outcomes.
The company recently announced its financial results for the fiscal first quarter of 2023, which ended on March 31, 2023. The report shows that Bio Rad Laboratories Inc has had a significant improvement in earnings compared to the previous year.






 

Bio Rad Laboratories Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com